Mr. Sebastian Gabriel De La Calle, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: Brian D. Allgood Army Community Hospital, Usag-humphreys, Bldg # 3030, Unit 15245, Apo, AP 96271 Phone: 315-737-2836 |
Dr. Alex Heaton Gubler, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: Paf 374 Op Med Readiness Sq Ffgfz0, Apo, AP 96328 Phone: 813-325-9822 |
News Archive
In an advance toward solving a 50-year-old mystery, scientists are reporting new evidence on how the fluoride in drinking water, toothpastes, mouth rinses and other oral-care products prevents tooth decay.
Human Genome Sciences today announced an agreement with GlaxoSmithKline under which GlaxoSmithKline has acquired exclusive worldwide rights to develop and commercialize Albugon (albumin-glucagon-like peptide-1, GLP-1), a drug currently in late-stage preclinical development by Human Genome Sciences for potential use in the treatment of diabetes.
OphthaliX Inc., a clinical-stage company focused on developing products that treat and improve sight for people living with ophthalmic disorders, and a subsidiary of Can-Fite BioPharma Ltd., announced today it has launched an updated website, www.ophthaliX.com, to reflect its definitive agreement to acquire Israel-based Improved Vision Systems Ltd.
Scientists at the National Institutes of Health have used RNA interference (RNAi) technology to reveal dozens of genes which may represent new therapeutic targets for treating Parkinson's disease. The findings also may be relevant to several diseases caused by damage to mitochondria, the biological power plants found in cells throughout the body.
Healthpoint today announced that the U.S. Food and Drug Administration has granted approval to manufacture commercial supplies of Collagenase SANTYL Ointment, a biologic enzymatic debriding agent, at DPT Laboratories' Center of Excellence for Sterile & Specialty Products facility in Lakewood, New Jersey.
› Verified 1 days ago